Pharmaceutical group · Sweden
Pharmacia
A group of 21 companies with 134 medicines in 5 countries.
Group structure
21 companies in 8 countries
Loading…
Pharmaceutical group · Sweden
A group of 21 companies with 134 medicines in 5 countries.
21 companies in 8 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 134
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CADUET10mg base; 10mg base | 10mg base; 20mg base | 10mg base; 40mg base | 10mg base; 80mg base | 2.5mg base; 10mg base | 2.5mg base; 20mg base | 2.5mg base; 40mg base | 5mg base; 10mg base | 5mg base; 20mg base | 5mg base; 40mg base | 5mg base; 80mg base · Tablet | Amlodipine, Atorvastatin | United States | Marketed | 2004 |
| CARBOPLATINO PHARMACIA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG10 mg · Concentrado para solución para perfusión | Carboplatin | Spain | Marketed | 1998 |
| CISPLATINO PHARMACIA 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG1 mg · Concentrado para solución para perfusión | Cisplatin | Spain | Marketed | 1998 |
| DILANTIN50mg · Tablet, chewable | Phenytoin | United States | Marketed | 1979 |
| GELFOAM | Esponja esteril gelatina absorvivel, Gelatina absorvível | Brazil | Authorised | 2001 |
| GENOTROPIN13.8mg/vial | 5.8mg/vial · Injectable | Somatropin | United States | Marketed | 1995 |
| GENOTROPIN PRESERVATIVE FREE0.2mg/vial | 0.4mg/vial | 0.6mg/vial | 0.8mg/vial | 1.2mg/vial | 1.4mg/vial | 1.5mg/vial | 1.6mg/vial | 1.8mg/vial | 1mg/vial | 2mg/vial · Injectable | Somatropin | United States | Marketed | 1995 |
| MAXAQUIN400mg base · Tablet | Lomefloxacin | United States | Not marketed | 1992 |
| SOMAVERT10mg/vial | 15mg/vial | 20mg/vial | 25mg/vial | 30mg/vial · Injectable | Pegvisomant | United States | Marketed | 2003 |
| ACETATO DE RETINOL + ASSOCIADOS | Brazil | Cancelled | 1999 | |
| ACETATO DE RETINOL + ASSOSSIACAO | Brazil | Cancelled | 1999 | |
| ACIDO ACETILSALICILICO | Brazil | Cancelled | 1999 | |
| ADRIBLASTINA | Doxorubicin | Brazil | Cancelled | 2003 |
| ADSPEC STERILE SOLUTION100 mg / ml · Solution | Spectinomycin | Canada | Cancelled | 1999 |
| ALBADRY SUSPENSION 40MG/ML400 mg / 10 ml · Suspension | Novobiocin | Canada | Cancelled | 1984 |
| ALBAMIX PREMIX55 G / Kg · Drug Premix | Novobiocin | Canada | Cancelled | 1993 |
| ALBRYN CREAM.5 % · Cream | Cetrimide | Canada | Cancelled | 1990 |
| ALDACTONE | Espironolactona | Brazil | Cancelled | 2002 |
| ALDAZIDA | Espironolactona, Hydrochlorothiazide | Brazil | Cancelled | 2003 |
| ALEXAN | Cytarabine | Brazil | Cancelled | 1997 |
| ANDRIODERMOL | Brazil | Cancelled | 1999 | |
| ARACYTIN | Cytarabine | Brazil | Cancelled | 1999 |
| AROMASIN | Exemestane | Brazil | Cancelled | 2000 |
| ATGAM | Brazil | Cancelled | 1999 | |
| Bextra | Valdecoxib | EU (EMA) | Withdrawn | 2003 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 97 | 1 | 96 | CompaniesAll medicines |
| Canada | 25 | 0 | 25 | CompaniesAll medicines |
| United States | 6 | 6 | 0 | CompaniesAll medicines |
| European Union (EMA) | 4 | 0 | 4 | CompaniesAll medicines |
| Spain | 2 | 2 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Report an error or request removalCorrections from the company itself are welcome.
Keep Pharmacia’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callLicence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.